Liberate Medical

Liberate Medical Reports Positive Pilot Trial Results of VentFree™ Respiratory Muscle Stimulator

Retrieved on: 
Monday, November 16, 2020
Biotechnology, Nursing, Health, FDA, Medical devices, Infectious diseases, Hospitals, Clinical trials, Medicine, Clinical medicine, Branches of biology, Electrotherapy, Electrical muscle stimulation, Functional electrical stimulation, Muscle atrophy, Liberate Medical, the VentFree Respiratory Muscle Stimulator

Liberate Medical today announced the results of a second randomized controlled pilot trial of its proprietary medical device, the VentFree Respiratory Muscle Stimulator, the only non-invasive and only breath-synchronized neuromuscular electrical stimulation device used to address respiratory muscle atrophy in mechanically ventilated patients.

Key Points: 
  • Liberate Medical today announced the results of a second randomized controlled pilot trial of its proprietary medical device, the VentFree Respiratory Muscle Stimulator, the only non-invasive and only breath-synchronized neuromuscular electrical stimulation device used to address respiratory muscle atrophy in mechanically ventilated patients.
  • VentFree is a promising and unique technique for providing respiratory muscle protective ventilation, commented first author Annemijn Jonkman, MSc, Amsterdam UMC.
  • The results from this EU study were combined with the results of a similar trial in Australia that was published last year.
  • The VentFree respiratory muscle stimulator contracts the abdominal muscles in mechanically ventilated patients using proprietary non-invasive electrical stimulation applied in synchrony with exhalation.

VentFree™ Respiratory Muscle Stimulator Receives FDA Emergency Use Authorization for Use During COVID-19 Pandemic

Retrieved on: 
Monday, May 4, 2020
Biotechnology, Nursing, Health, FDA, Medical devices, Infectious diseases, Hospitals, Clinical trials, Health, Respiratory therapy, Medicine, Medical ventilator, Food and Drug Administration, Emergency Use Authorization, Anesthesia, Emergency Use Authorization of VentFree, Liberate Medical

Fewer days on ventilation may also increase the availability of ventilators during the COVID-19 pandemic.

Key Points: 
  • Fewer days on ventilation may also increase the availability of ventilators during the COVID-19 pandemic.
  • Last year VentFree received FDA Breakthrough Device Designation and CE marking in the European Union.
  • Current methods of respiratory muscle training cannot be used when patients are sedated or delirious, which is common among critically ill patients.
  • VentFree has been authorized for the above emergency use by FDA under an Emergency Use Authorization.